Kusaba H - Search Results

1

Phase 2 study of modified irinotecan and bolus 5-fluorouracil/l-leucovorin in Japanese metastatic colorectal cancer patients.

Baba E, Fujishima H, Makiyama A, Uchino K, Tanaka R, Esaki T, Kusaba H, Mitsugi K, Nakano S, Akashi K. Baba E, et al. Among authors: kusaba h. Adv Ther. 2012 Mar;29(3):287-96. doi: 10.1007/s12325-012-0002-3. Epub 2012 Feb 10. Adv Ther. 2012. PMID: 22351434 Clinical Trial.

2

[Problems and prospects for combined chemotherapy with 5-fluorouracil and low-dose cisplatin].

Kusaba H, Mitsugi K, Nakano S, Saijo N. Kusaba H, et al. Gan To Kagaku Ryoho. 1999 Oct;26(11):1575-80. Gan To Kagaku Ryoho. 1999. PMID: 10553415 Review. Japanese.

3

In vitro sequence-dependent interaction between nedaplatin and paclitaxel in human cancer cell lines.

Tanaka R, Takii Y, Shibata Y, Ariyama H, Qin B, Baba E, Kusaba H, Mitsugi K, Harada M, Nakano S. Tanaka R, et al. Among authors: kusaba h. Cancer Chemother Pharmacol. 2005 Sep;56(3):279-85. doi: 10.1007/s00280-004-0991-y. Epub 2005 May 4. Cancer Chemother Pharmacol. 2005. PMID: 15875187

4

Synergistic interaction between oxaliplatin and SN-38 in human gastric cancer cell lines in vitro.

Tanaka R, Ariyama H, Qin B, Shibata Y, Takii Y, Kusaba H, Baba E, Mitsugi K, Harada M, Nakano S. Tanaka R, et al. Among authors: kusaba h. Oncol Rep. 2005 Sep;14(3):683-8. Oncol Rep. 2005. PMID: 16077975

5

Activated Src and Ras induce gefitinib resistance by activation of signaling pathways downstream of epidermal growth factor receptor in human gallbladder adenocarcinoma cells.

Qin B, Ariyama H, Baba E, Tanaka R, Kusaba H, Harada M, Nakano S. Qin B, et al. Among authors: kusaba h. Cancer Chemother Pharmacol. 2006 Nov;58(5):577-84. doi: 10.1007/s00280-006-0219-4. Epub 2006 Mar 11. Cancer Chemother Pharmacol. 2006. PMID: 16532343

6

In-vitro differential metabolism and activity of 5-fluorouracil between short-term, high-dose and long-term, low-dose treatments in human squamous carcinoma cells.

Qin B, Tanaka R, Ariyama H, Shibata Y, Arita S, Kusaba H, Baba E, Harada M, Nakano S. Qin B, et al. Among authors: kusaba h. Anticancer Drugs. 2006 Apr;17(4):439-43. doi: 10.1097/01.cad.0000203380.22361.6c. Anticancer Drugs. 2006. PMID: 16550002

7

In-vitro schedule-dependent interaction between oxaliplatin and 5-fluorouracil in human gastric cancer cell lines.

Qin B, Tanaka R, Shibata Y, Arita S, Ariyama H, Kusaba H, Baba E, Harada M, Nakano S. Qin B, et al. Among authors: kusaba h. Anticancer Drugs. 2006 Apr;17(4):445-53. doi: 10.1097/01.cad.0000198912.98442.cd. Anticancer Drugs. 2006. PMID: 16550003

8

Metastatic basaloid-squamous cell carcinoma of the esophagus treated by 5-fluorouracil and cisplatin.

Shibata Y, Baba E, Ariyama H, Miki R, Ogami N, Arita S, Qin B, Kusaba H, Mitsugi K, Noshiro H, Yao T, Nakano S. Shibata Y, et al. Among authors: kusaba h. World J Gastroenterol. 2007 Jul 14;13(26):3634-7. doi: 10.3748/wjg.v13.i26.3634. World J Gastroenterol. 2007. PMID: 17659717 Free PMC article.

9

Infusional 5-fluorouracil and cisplatin as first-line chemotherapy in patients with carcinoma of unknown primary site.

Kusaba H, Shibata Y, Arita S, Ariyama H, Baba E, Mitsugi K, Harada M, Nakano S. Kusaba H, et al. Med Oncol. 2007;24(2):259-64. doi: 10.1007/BF02698049. Med Oncol. 2007. PMID: 17848753

10

B cell activation regulates exosomal HLA production.

Arita S, Baba E, Shibata Y, Niiro H, Shimoda S, Isobe T, Kusaba H, Nakano S, Harada M. Arita S, et al. Among authors: kusaba h. Eur J Immunol. 2008 May;38(5):1423-34. doi: 10.1002/eji.200737694. Eur J Immunol. 2008. PMID: 18425730 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters